Advertisement
U.S. markets open in 8 hours 4 minutes

PaxMedica, Inc. (PXMD)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.6380-0.0210 (-3.19%)
At close: 04:00PM EST
0.6100 -0.03 (-4.39%)
After hours: 08:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Relative Strength Index (RSI)

Relative Strength Index (RSI)

Previous Close0.6590
Open0.6700
Bid0.0000 x 1000
Ask0.0000 x 2200
Day's Range0.5850 - 0.6700
52 Week Range0.3720 - 48.4500
Volume132,016
Avg. Volume972,757
Market Cap2.89M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-21.9000
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for PXMD

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • NewMediaWire

      IBN Highlights PaxMedica's Video Release on Transformative ASD Study

      LOS ANGELES, CA - (NewMediaWire) - January 18, 2024 - (InvestorBrandNetwork via NewMediaWire) - This original article is powered by IBN, a financial news, content creation and publishing company.In a significant development for the neurological disor...

    • NewMediaWire

      PaxMedica on Promising Path to Address Unmet ASD Needs

      LOS ANGELES, CA - (NewMediaWire) - January 17, 2024 - (InvestorBrandNetwork via NewMediaWire) - This original article is powered by IBN, a financial news, content creation and publishing company.PaxMedica (NASDAQ: PXMD) is a clinical-stage biopharmac...

    • NewMediaWire

      PaxMedica Files 8-K Following Nasdaq Compliance Achievement

      LOS ANGELES, CA - (NewMediaWire) - December 22, 2023 - (InvestorBrandNetwork via NewMediaWire) - This original article is powered by IBN, a financial news, content creation and publishing company.In a significant corporate update, PaxMedica (NASDAQ: ...